GlaxoSmithKline Pharmaceuticals has informed that the Company has received the CIT-Appeal Order under Section 250 read with section 43(3) for Assessment Year 2004-2005, issuing income tax refund of Rs 49.54 cr (including interest) on 8th April 2025.
The above information is a part of company’s filings submitted to BSE.